[go: up one dir, main page]

AR009282A1 - Inhibidores moleculares de adhesion celular mediados por integrina beta2 - Google Patents

Inhibidores moleculares de adhesion celular mediados por integrina beta2

Info

Publication number
AR009282A1
AR009282A1 ARP970103784A ARP970103784A AR009282A1 AR 009282 A1 AR009282 A1 AR 009282A1 AR P970103784 A ARP970103784 A AR P970103784A AR P970103784 A ARP970103784 A AR P970103784A AR 009282 A1 AR009282 A1 AR 009282A1
Authority
AR
Argentina
Prior art keywords
cell adhesion
beta2
integrine
mediated cell
molecular inhibitors
Prior art date
Application number
ARP970103784A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR009282A1 publication Critical patent/AR009282A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones y métodos, que utilizan un compuesto de formula (I) para reducir o controlar la inflamacion y el tratamiento de estados patologicosmediados por la adhesion intracelular. Más particularmente, la presente invencion se refierea composiciones y métodos para bloquear o modular lafuncion de la familia de integrina Beta2 en moléculas de adhesion celular.
ARP970103784A 1996-08-21 1997-08-20 Inhibidores moleculares de adhesion celular mediados por integrina beta2 AR009282A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70111396A 1996-08-21 1996-08-21

Publications (1)

Publication Number Publication Date
AR009282A1 true AR009282A1 (es) 2000-04-12

Family

ID=24816122

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103784A AR009282A1 (es) 1996-08-21 1997-08-20 Inhibidores moleculares de adhesion celular mediados por integrina beta2

Country Status (4)

Country Link
AR (1) AR009282A1 (es)
AU (1) AU4152297A (es)
WO (1) WO1998007432A1 (es)
ZA (1) ZA977471B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
ES2147163B1 (es) * 1999-01-25 2001-03-01 Esp Farmaceuticas Centrum Sa Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion.

Also Published As

Publication number Publication date
AU4152297A (en) 1998-03-06
ZA977471B (en) 1999-02-22
WO1998007432A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
DK0806933T3 (da) Præparater og fremgangsmåder til reduktion af hudirritation
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
DE69608916D1 (de) Verbindungen und ihre zusammensetzungen mit entzündungshemmenden und anti-thrombotischen wirkungen
ES2196630T3 (es) Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas.
NO994877L (no) Kalsilytiske forbindelser
BRPI0410348A (pt) compostos e usos dos mesmos na modulação de amilóide-beta
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
HUP9900936A1 (hu) Izocianátalapú készítmények, bevonatként történő alkalmazásuk és az így előállított bevonatok
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
BR9903571A (pt) Método para inibição de glicogênio fosforilase humano
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
BR0109703A (pt) Derivados de piperazina
BR0011172A (pt) Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
BR9811948A (pt) Secretores de hormÈnio do crescimento
TR199801579T2 (xx) Polimerlere dayanan b�cek �ld�r�c� bile�imler.
DK1053000T3 (da) Midler og fremgangsmåder til beskyttelse, behandling og udbedring af bindevæv
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
BR9814188A (pt) "agonistas de 5-ht1f"
AR009282A1 (es) Inhibidores moleculares de adhesion celular mediados por integrina beta2
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida